Courts Deal Setbacks to Seroquel Plaintiffs as Expert Testimonies Falter in Ongoing Litigation
WILMINGTON, Del. — The ongoing product liability litigation over AstraZeneca’s antipsychotic drug Seroquel has seen a troubling trend emerge for plaintiffs. A Delaware state court judge dismissed a case on June 9, marking the third such dismissal linked to the drug. The judge determined that the plaintiff failed to provide adequate expert medical testimony to demonstrate a connection between Seroquel and her health issues. The following day, a fourth case was dismissed at the plaintiff’s request. These dismissals come amid a larger pattern of adverse rulings in the federal multidistrict litigation (MDL) concerning Seroquel. Thousands … Read more